A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer
Titel:
A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer
Auteur:
Morganti, Stefania Chu, Xiangying Ballinger, Tarah J. Unni, Nisha Sinclair, Sarah Wesolowski, Robert Pereslete, Alyssa M. Lange, Paulina Tayob, Nabihah Lin, Nancy U. Leone, Jose P. Krop, Ian E. Tolaney, Sara M. Parsons, Heather A.